Multifocal hypodense nodules or masses on CECT with delayed enhancement
• Gastrointestinal
50% of patients with cutaneous Kaposi sarcoma (KS) will have GI tract involvement
Upper GI tract (especially stomach and duodenum) most common, but can affect any part of GI tract
Submucosal nodules or polypoid masses (< 3 cm) most common, although larger infiltrative masses possible
Regional enhancing lymphadenopathy common
Lesions may cause intussusception or obstruction
Submucosal nodules on barium studies with ulceration may appear as “target” or bull’s-eye lesions
• Lymphadenopathy
Most commonly involves retroperitoneal lymph nodes
Commonly hypervascular/avidly enhancing
TOP DIFFERENTIAL DIAGNOSES
• Lymphoma
• Hepatic opportunistic infections
• Intestinal opportunistic infections
• Other causes of hypervascular lymphadenopathy
Hypervascular lymph node metastases
Castleman disease
• Other causes of multiple hepatic/splenic nodules
Metastatic disease from other malignancies
Sarcoid
Hepatic microabscesses or fungal infection
PATHOLOGY
• Associated with human herpesvirus type 8 (HHV8) infection and variable cofactors
• 4 clinical subtypes of KS
Classic (sporadic) KS: Affects elderly men of Eastern European or Mediterranean origin with visceral involvement uncommon
– Indolent cutaneous involvement of lower extremities
Endemic (African) KS: Not associated with HIV, and accounts for up to 1/2 of all cancers in parts of Africa
Iatrogenic (organ transplant-related) KS: Typically develops 1-2 years after transplant, with visceral involvement more likely with heart and liver transplants
Epidemic (AIDS-related) KS: ↓ prevalence with antiretroviral therapies
TERMINOLOGY
Abbreviations
• Kaposi sarcoma (KS)
Definitions
Buy Membership for Radiology Category to continue reading. Learn more here